{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:44:30Z","timestamp":1780393470493,"version":"3.54.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004608","name":"Jiangsu Province Natural Science Foundation","doi-asserted-by":"publisher","award":["BK20211075"],"award-info":[{"award-number":["BK20211075"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007824","name":"Soochow University","doi-asserted-by":"publisher","award":["H230028"],"award-info":[{"award-number":["H230028"]}],"id":[{"id":"10.13039\/501100007824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007824","name":"Soochow University","doi-asserted-by":"publisher","award":["H240669"],"award-info":[{"award-number":["H240669"]}],"id":[{"id":"10.13039\/501100007824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371365"],"award-info":[{"award-number":["82371365"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.cca.2025.120330","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T22:40:15Z","timestamp":1745534415000},"page":"120330","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Relative change rate of anti-acetylcholine receptor antibodies concentration Correlates with the recurrence of myasthenia gravis in AChR-Abs-positive patients"],"prefix":"10.1016","volume":"574","author":[{"given":"Jingluan","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hairong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzheng","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueping","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingshun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7324-7982","authenticated-orcid":false,"given":"Qun","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cca.2025.120330_b0005","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0300-595X(83)80029-2","article-title":"Acetylcholine receptors and myasthenia gravis","volume":"12","author":"Vincent","year":"1983","journal-title":"Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.cca.2025.120330_b0010","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/WCO.0b013e328364d6cd","article-title":"Autoimmune myasthenia gravis: autoantibody mechanisms and new developments on immune regulation","volume":"26","author":"Le Panse","year":"2013","journal-title":"Curr Opin Neurol"},{"issue":"26","key":"10.1016\/j.cca.2025.120330_b0015","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia Gravis","volume":"375","author":"Gilhus","year":"2016","journal-title":"N Engl J Med"},{"issue":"9274","key":"10.1016\/j.cca.2025.120330_b0020","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/S0140-6736(00)05186-2","article-title":"Myasthenia gravis","volume":"357","author":"Vincent","year":"2001","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.cca.2025.120330_b0025","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1055\/s-0035-1558975","article-title":"Myasthenia Gravis","volume":"35","author":"Gwathmey","year":"2015","journal-title":"Semin Neurol"},{"key":"10.1016\/j.cca.2025.120330_b0030","doi-asserted-by":"crossref","unstructured":"W.D. Phillips, A. Vincent, Pathogenesis of myasthenia gravis: update on disease types, models, and mechanisms, F1000Res 5 (2016).","DOI":"10.12688\/f1000research.8206.1"},{"issue":"5","key":"10.1016\/j.cca.2025.120330_b0035","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrneurol.2016.44","article-title":"Myasthenia gravis - autoantibody characteristics and their implications for therapy","volume":"12","author":"Gilhus","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.cca.2025.120330_b0040","first-page":"212","article-title":"Autoantibody Specificities in Myasthenia Gravis","volume":"11","author":"Lazaridis","year":"2020","journal-title":"Implications for Improved Diagnostics and Therapeutics, Front Immunol"},{"key":"10.1016\/j.cca.2025.120330_b0045","doi-asserted-by":"crossref","first-page":"776","DOI":"10.3389\/fimmu.2020.00776","article-title":"Autoimmune Pathology in Myasthenia Gravis Disease Subtypes Is Governed by Divergent Mechanisms of Immunopathology","volume":"11","author":"Fichtner","year":"2020","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.cca.2025.120330_b0050","doi-asserted-by":"crossref","DOI":"10.3390\/cells8070671","article-title":"Myasthenia Gravis: Pathogenic Effects of Autoantibodies on Neuromuscular Architecture","volume":"8","author":"Koneczny","year":"2019","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.cca.2025.120330_b0055","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/CND.0b013e31828a0090","article-title":"Correlation between acetylcholine receptor antibody levels and thymic pathology in myasthenia gravis: a review","volume":"14","author":"Huang","year":"2013","journal-title":"J Clin Neuromuscul Dis"},{"issue":"5","key":"10.1016\/j.cca.2025.120330_b0060","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/WCO.0000000000000473","article-title":"Myasthenia gravis: new developments in research and treatment","volume":"30","author":"Evoli","year":"2017","journal-title":"Curr Opin Neurol"},{"issue":"3","key":"10.1016\/j.cca.2025.120330_b0065","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11940-002-0037-x","article-title":"Thymectomy for Myasthenia Gravis","volume":"4","author":"Gronseth","year":"2002","journal-title":"Curr Treat Options Neurol"},{"issue":"6","key":"10.1016\/j.cca.2025.120330_b0070","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0165-5728(84)90065-1","article-title":"A practical enzyme immunoassay for anti-acetylcholine receptor antibodies in myasthenia gravis","volume":"6","author":"Furukawa","year":"1984","journal-title":"J Neuroimmunol"},{"issue":"7","key":"10.1016\/j.cca.2025.120330_b0075","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/(SICI)1097-4598(199707)20:7<800::AID-MUS3>3.0.CO;2-B","article-title":"Detection of antibody classes and subpopulations in myasthenia gravis patients using a new nonradioactive enzyme immunoassay","volume":"20","author":"Gotti","year":"1997","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.cca.2025.120330_b0080","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.cca.2022.06.017","article-title":"Optimization of the cut-offs in acetylcholine receptor antibodies and diagnostic performance in myasthenia gravis patients","volume":"533","author":"Shao","year":"2022","journal-title":"Clin Chim Acta"},{"issue":"1","key":"10.1016\/j.cca.2025.120330_b0085","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.nmd.2013.09.013","article-title":"Outcome of children with acetylcholine receptor (AChR) antibody positive juvenile myasthenia gravis following thymectomy","volume":"24","author":"Heng","year":"2014","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.cca.2025.120330_b0090","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000212371","article-title":"Myasthenia gravis with anti-acetylcholine receptor antibodies","volume":"26","author":"Meriggioli","year":"2009","journal-title":"Front Neurol Neurosci"},{"issue":"9","key":"10.1016\/j.cca.2025.120330_b0095","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.autrev.2013.03.001","article-title":"Pathophysiology of myasthenia gravis with antibodies to the acetylcholine receptor, muscle-specific kinase and low-density lipoprotein receptor-related protein 4","volume":"12","author":"Verschuuren","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"13","key":"10.1016\/j.cca.2025.120330_b0100","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1056\/NEJM198209233071301","article-title":"Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis","volume":"307","author":"Drachman","year":"1982","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.cca.2025.120330_b0105","first-page":"289","article-title":"Relationship between anti-acetylcholine receptor antibody titres and severity of myasthenia gravis","volume":"59","author":"Aurangzeb","year":"2009","journal-title":"J Pak Med Assoc"},{"issue":"11","key":"10.1016\/j.cca.2025.120330_b0110","first-page":"1054","article-title":"Antibody to acetylcholine receptor in myasthenia gravis","volume":"26","author":"Lindstrom","year":"1976","journal-title":"Prevalence, Clinical Correlates, and Diagnostic Value, Neurology"},{"issue":"7","key":"10.1016\/j.cca.2025.120330_b0115","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/jnnp.43.7.590","article-title":"Anti-acetylcholine receptor antibodies","volume":"43","author":"Vincent","year":"1980","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.cca.2025.120330_b0120","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1749-6632.1981.tb33739.x","article-title":"Patterns of acetylcholine receptor antibody fluctuation in myasthenia gravis","volume":"377","author":"Seybold","year":"1981","journal-title":"Ann N Y Acad Sci"},{"issue":"7","key":"10.1016\/j.cca.2025.120330_b0125","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.2203","article-title":"No correlation between acetylcholine receptor antibody concentration and individual clinical symptoms of myasthenia gravis: A systematic retrospective study involving 67 patients","volume":"11","author":"Wang","year":"2021","journal-title":"Brain Behav"},{"issue":"4","key":"10.1016\/j.cca.2025.120330_b0130","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/mus.23944","article-title":"Muscle Study, Does change in acetylcholine receptor antibody level correlate with clinical change in myasthenia gravis?","volume":"49","author":"Sanders","year":"2014","journal-title":"Muscle Nerve"},{"issue":"9","key":"10.1016\/j.cca.2025.120330_b0135","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1136\/jnnp-2012-302705","article-title":"Antibodies against the main immunogenic region of the acetylcholine receptor correlate with disease severity in myasthenia gravis","volume":"83","author":"Masuda","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"10.1016\/j.cca.2025.120330_b0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114060","article-title":"Repeated acetylcholine receptor antibody-concentrations and association to clinical myasthenia gravis development","volume":"9","author":"Heldal","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2025.120330_b0145","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2020-325511","article-title":"Rate of change in acetylcholine receptor antibody levels predicts myasthenia gravis outcome","author":"Kojima","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"10.1016\/j.cca.2025.120330_b0150","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1136\/jnnp-2021-326480","article-title":"Using AChR antibody titres to predict treatment responses in myasthenia gravis","volume":"92","author":"Vincent","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.cca.2025.120330_b0155","doi-asserted-by":"crossref","first-page":"4","DOI":"10.17712\/nsj.2021.1.20190041","article-title":"Prevalence and risk factors of myasthenia gravis recurrence post-thymectomy","volume":"26","author":"Alqarni","year":"2021","journal-title":"Neurosciences (Riyadh)"},{"issue":"1","key":"10.1016\/j.cca.2025.120330_b0160","first-page":"106","article-title":"Thymoma-associated myasthenia gravis: Clinical features and predictive value of antiacetylcholine receptor antibodies in the risk of recurrence of thymoma, Thorac","volume":"12","author":"De Rosa","year":"2021","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.cca.2025.120330_b0165","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/00207454.2017.1344237","article-title":"Factors affecting outcome in ocular myasthenia gravis","volume":"128","author":"Mazzoli","year":"2018","journal-title":"Int J Neurosci"},{"issue":"3","key":"10.1016\/j.cca.2025.120330_b0170","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s13760-018-0943-7","article-title":"Antibody profile may predict outcome in ocular myasthenia gravis","volume":"118","author":"Galassi","year":"2018","journal-title":"Acta Neurol Belg"},{"issue":"2","key":"10.1016\/j.cca.2025.120330_b0175","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1474-4422(21)00297-0","article-title":"Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders","volume":"21","author":"Punga","year":"2022","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.cca.2025.120330_b0180","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/4337399","article-title":"Clinical Significance of OX40 and OX40 Ligand in the Peripheral Blood of Patients with Myasthenia Gravis","volume":"2022","author":"Zhou","year":"2022","journal-title":"J Immunol Res"},{"issue":"1\u20132","key":"10.1016\/j.cca.2025.120330_b0185","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cccn.2005.05.035","article-title":"A sensitive non-isotopic assay for acetylcholine receptor autoantibodies","volume":"364","author":"Hewer","year":"2006","journal-title":"Clin Chim Acta"},{"issue":"5","key":"10.1016\/j.cca.2025.120330_b0190","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1136\/jnnp.41.5.394","article-title":"Determination of acetylcholine receptor antibody in myasthenia gravis: clinical usefulness and pathogenetic implications","volume":"41","author":"Lefvert","year":"1978","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.cca.2025.120330_b0195","first-page":"45","article-title":"Comparison of diagnostic tests in myasthenia gravis","volume":"19","author":"Nicholson","year":"1983","journal-title":"Clin Exp Neurol"},{"issue":"3","key":"10.1016\/j.cca.2025.120330_b0200","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0022-510X(83)90096-5","article-title":"Anti-acetylcholine receptor antibodies in myasthenia gravis. Part 2. Clinical and serological follow-up of individual patients","volume":"58","author":"Oosterhuis","year":"1983","journal-title":"J Neurol Sci"},{"issue":"1","key":"10.1016\/j.cca.2025.120330_b0205","first-page":"82","article-title":"Acetylcholine receptor antibody in myasthenia gravis: predominance of IgG subclasses 1 and 3","volume":"67","author":"Rodgaard","year":"1987","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"10.1016\/j.cca.2025.120330_b0210","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1136\/jnnp.56.5.496","article-title":"Clinical implementation of anti-acetylcholine receptor antibodies","volume":"56","author":"Somnier","year":"1993","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"10.1016\/j.cca.2025.120330_b0215","doi-asserted-by":"crossref","first-page":"965","DOI":"10.29271\/jcpsp.2021.08.965","article-title":"Relationship between Low and High Anti-acetylcholine Receptor Antibody Titers and Clinical Severity in Myasthenia Gravis","volume":"31","author":"Ullah","year":"2021","journal-title":"J Coll Physicians Surg Pak"},{"issue":"1","key":"10.1016\/j.cca.2025.120330_b0220","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1073\/pnas.79.1.188","article-title":"Specificities of antibodies to acetylcholine receptors in sera from myasthenia gravis patients measured by monoclonal antibodies","volume":"79","author":"Tzartos","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.cca.2025.120330_b0225","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s10072-015-2236-8","article-title":"Both binding and blocking antibodies correlate with disease severity in myasthenia gravis","volume":"36","author":"Kang","year":"2015","journal-title":"Neurol Sci"},{"issue":"1","key":"10.1016\/j.cca.2025.120330_b0230","doi-asserted-by":"crossref","first-page":"11230","DOI":"10.1038\/s41598-020-68185-x","article-title":"AChR antibodies show a complex interaction with human skeletal muscle cells in a transcriptomic study","volume":"10","author":"Hong","year":"2020","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.cca.2025.120330_b0235","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1007\/s00415-019-09667-5","article-title":"Frequency and clinical features of treatment-refractory myasthenia gravis","volume":"267","author":"Rath","year":"2020","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.cca.2025.120330_b0240","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s12016-016-8558-3","article-title":"Thymic Germinal Centers and Corticosteroids in Myasthenia Gravis: an Immunopathological Study in 1035 Cases and a Critical Review","volume":"52","author":"Truffault","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.cca.2025.120330_b0245","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1749-6632.1987.tb51321.x","article-title":"Clinical correlations of antibodies that bind, block, or modulate human acetylcholine receptors in myasthenia gravis","volume":"505","author":"Howard","year":"1987","journal-title":"Ann N Y Acad Sci"},{"issue":"7","key":"10.1016\/j.cca.2025.120330_b0250","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1080\/14737175.2018.1491310","article-title":"Advances in autoimmune myasthenia gravis management","volume":"18","author":"Wang","year":"2018","journal-title":"Expert Rev Neurother"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125002098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125002098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:06:06Z","timestamp":1762113966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898125002098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":50,"alternative-id":["S0009898125002098"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2025.120330","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relative change rate of anti-acetylcholine receptor antibodies concentration Correlates with the recurrence of myasthenia gravis in AChR-Abs-positive patients","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2025.120330","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120330"}}